Industries

Life Sciences Antitrust & Competition

Overview

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

01

Successful defense of Amgen-Horizon merger

CRA’s Life Sciences consultants provided economic expert assistance to Amgen in defending against a FTC challenge to its acquisition of Horizon Therapeutics....
View engagement
02

CRA Calculates State Medicaid Damages for Anticompetitive Harm

On behalf of a party to a reverse payment settlement, CRA’s life sciences consultants were asked to calculate damages to a state Medicaid program. The CRA...
View engagement
03

FTC reverses Administrative Law Judge on Illumina/Grail

On April 3, the Federal Trade Commission (FTC) reversed the decision of an Administrative Law Judge by finding that Illumina’s $7.1 billion acquisition of...
View engagement